Ottobock has acquired approximately 10% of ONWARD Medical's share capital, and the company has extended its cash runway to two years or more.
Organizations Involved
Ottobock SE & Co. KGaA
Company Description
ONWARD® Medical is a medical technology company creating therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disabilities. The Company has developed ARC Therapy™, which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA).